ask="2.5000"
ask_size="500"
average_daily_volume="211529"
bid="1.4900"
bid_size="800"
book_value="0.7310"
change="-0.0001"
change_from_200_day_moving_average="0.5122"
change_from_50_day_moving_average="0.4061"
change_from_52_week_high="-0.3201"
change_From_52_week_low="0.8599"
change_in_percent="-0.0046%"
close="2.1599"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4680"
ebitda="-18.07M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.6200"
ex_dividend_date="N/A"
float_shares="32403000"
high="2.1800"
high_52_weeks="2.4800"
last_trade_date="2/3/2017"
last_trade_price="2.1599"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.1204"
low_52_weeks="1.3000"
market_capitalization="93.00M"
moving_average_200_day="1.6477"
moving_average_50_day="1.7538"
name="Pieris Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.0000"
open="2.1600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+31.0842%"
percent_change_from_50_day_moving_average="+23.1582%"
percent_change_from_52_week_high="-12.9073%"
percent_change_from_52_week_low="+66.1462%"
previous_close="2.1600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.9549"
price_per_sales="17.7357"
revenue="5.24M"
shares_outstanding="43058000"
short_ratio="1.4400"
stock_exchange="NCM"
symbol="PIRS"
volume="131592"
weeks_range_52="1.3000 - 2.4800"
